Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Offer 3.5M Shares

NEW YORK, May 12 (GenomeWeb News) - Illumina has filed a statement with the US Securities and Exchange Commission to publicly offer 3.5 million shares of its common stock.

 

In addition, the underwriters of the offering will be granted the right to purchase an additional 525,000 shares of common stock.

 

Goldman Sachs and Merrill Lynch are acting as joint bookrunning and co-lead managers of the offering, while Cowen and Company and Robert W. Baird are acting as co-managers of the offering.

 

The company's shares were trading at $27.30 in mid-afternoon trading.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.